Bio-Techne Company Overview

What is the Stock Ticker for Bio-Techne?

The stock ticker for Bio-Techne is TECH.

Where is the Bio-Techne headquarters?

The headquarters of Bio-Techne is located in Minneapolis, Minnesota, USA.

What Does Bio-Techne Do?

Bio-Techne is a global life sciences company that develops and manufactures innovative tools and solutions for the research and clinical diagnostic markets. Their products include antibodies, proteins, assays, and instruments used in areas such as cancer research, stem cell research, and drug discovery. They also offer diagnostic tests for conditions such as cancer and autoimmune diseases.

How Does Bio-Techne Make Money?

Bio-Techne is a global life sciences company that provides innovative solutions for the research and clinical diagnostic markets. The company operates through three segments: Protein Sciences, Diagnostics, and Genomics.

Protein Sciences segment: This segment provides products and services that are used in research and clinical applications. The products include antibodies, proteins, immunoassays, and other reagents. The services include custom protein production, assay development, and protein analysis. The Protein Sciences segment generates revenue by selling these products and services to academic, biotech, and pharmaceutical customers.

Diagnostics segment: This segment provides diagnostic products and services for the clinical laboratory market. The products include assays, controls, and reagents for use in clinical chemistry, hematology, and immunology testing. The services include laboratory testing and consulting services. The Diagnostics segment generates revenue by selling these products and services to clinical laboratories and hospitals.

Genomics segment: This segment provides products and services for the genomics research market. The products include genomic analysis tools, gene expression assays, and next-generation sequencing products. The services include genomic analysis and sequencing services. The Genomics segment generates revenue by selling these products and services to academic, biotech, and pharmaceutical customers.

In summary, Bio-Techne makes money by selling products and services to customers in the research and clinical diagnostic markets. The company's revenue is generated through the sale of antibodies, proteins, immunoassays, diagnostic products, and genomics products, as well as through custom protein production, assay development, protein analysis, laboratory testing, and consulting services.

Who Founded Bio-Techne?

Bio-Techne was founded by Charles R. Kummeth in 1976.

What is the History of Bio-Techne?

Bio-Techne is a global life sciences company that provides innovative solutions for the research and clinical diagnostic markets. The company was founded in 1976 as Techne Corporation, a manufacturer of temperature control equipment for laboratory research. In the 1980s, Techne expanded its product offerings to include molecular biology reagents and instruments.

In 2014, Techne Corporation changed its name to Bio-Techne to reflect its focus on the life sciences industry. Today, Bio-Techne offers a wide range of products and services, including antibodies, proteins, immunoassays, genomic analysis tools, and clinical diagnostic assays.

Over the years, Bio-Techne has grown through a combination of organic growth and strategic acquisitions. Notable acquisitions include R&D Systems, Novus Biologicals, ProteinSimple, and Exosome Diagnostics. These acquisitions have allowed Bio-Techne to expand its product offerings and enter new markets.

Bio-Techne is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. The company is committed to advancing the field of life sciences through innovative products and services that enable researchers and clinicians to better understand and treat human disease.

What Industry is Bio-Techne In?

Bio-Techne is in the biotechnology and life sciences industry.

What Are Bio-Techne's Competitive Advantages?

1. Strong Research and Development Capabilities: Bio-Techne has a strong research and development team that is dedicated to developing innovative products and technologies. This enables the company to stay ahead of its competitors and offer unique solutions to its customers.

2. Diversified Product Portfolio: Bio-Techne offers a wide range of products and services in the life sciences industry, including antibodies, proteins, assays, and instruments. This diversification helps the company to mitigate risks and generate revenue from multiple sources.

3. Strong Brand Recognition: Bio-Techne has a strong brand reputation in the life sciences industry, which helps the company to attract and retain customers. The company's products are known for their quality, reliability, and accuracy.

4. Global Presence: Bio-Techne has a global presence with operations in North America, Europe, and Asia. This enables the company to serve customers in different regions and tap into new markets.

5. Strong Distribution Network: Bio-Techne has a strong distribution network that enables the company to reach customers in different regions. The company has partnerships with distributors and resellers, which helps to expand its reach and increase sales.

What Are Bio-Techne's Competitive Threats?

Some competitive threats to Bio-Techne include:

1. Other biotech companies: There are many other biotech companies that offer similar products and services as Bio-Techne. These companies may have better technology, more resources, or a larger market share, which could make it difficult for Bio-Techne to compete.

2. Economic downturns: Economic downturns can impact the demand for Bio-Techne's products and services. If customers have less money to spend, they may be less likely to purchase Bio-Techne's products.

3. Regulatory changes: Changes in regulations or laws could impact Bio-Techne's ability to operate or sell its products. For example, if new regulations are put in place that make it more difficult to get FDA approval for new products, Bio-Techne's growth could be impacted.

4. Intellectual property disputes: Bio-Techne's products and services may be subject to intellectual property disputes, which could impact the company's ability to sell its products or services.

5. Technological advancements: Technological advancements could make Bio-Techne's products or services obsolete or less desirable. For example, if a new technology is developed that is more effective than Bio-Techne's products, customers may switch to the new technology.

Who Are Some of the Competitors of Bio-Techne?

Some of the competitors of Bio-Techne include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, and Illumina.

What Are Some of Bio-Techne's Products and Services?

Some notable products and services from Bio-Techne include:

1. Protein research tools: Bio-Techne offers a wide range of protein research tools, including antibodies, recombinant proteins, ELISA kits, and more.

2. Cell culture products: The company provides a variety of cell culture products, such as media, sera, and supplements.

3. Genomics and proteomics solutions: Bio-Techne offers genomics and proteomics solutions, including RNA sequencing, gene expression analysis, and protein analysis.

4. Clinical diagnostic products: The company provides clinical diagnostic products, such as immunoassays and molecular diagnostic tests.

5. Stem cell research tools: Bio-Techne offers stem cell research tools, including stem cell culture media, differentiation kits, and antibodies.

6. Contract manufacturing services: The company provides contract manufacturing services for biologics, including recombinant proteins, antibodies, and viral vectors.

7. Custom antibody development: Bio-Techne offers custom antibody development services for research and diagnostic applications.